Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats.

Systemic exposure to N-methyl-d-aspartate (NMDA) receptor antagonists can lead to psychosis and prefrontal cortex (PFC)-dependent behavioral impairments. Agonists of metabotropic glutamate 2/3 (mGlu2/3) receptors ameliorate the adverse behavioral effects of NMDA antagonists in humans and laboratory animals, and are being considered as a novel treatment for some symptoms of schizophrenia. Despite the compelling behavioral data, the cellular mechanisms by which potentiation of mGlu2/3 receptor function attenuates the effects of NMDA receptor hypofunction remain unclear. In freely moving rats, we recorded the response of medial PFC (prelimbic) single units to treatment with the NMDA antagonist MK801 and assessed the dose-dependent effects of pre- or posttreatment with the mGlu2/3 receptor agonist LY354740 on this response. NMDA receptor antagonist-induced behavioral stereotypy was measured during recording because it may relate to the psychotomimetic properties of this treatment and is dependent on the functional integrity of the PFC. In most PFC neurons, systemic administration of MK801 increased the spontaneous firing rate, decreased the variability of spike trains, and disrupted patterns of spontaneous bursts. Given alone, LY354740 (1, 3, and 10 mg/kg) decreased spontaneous activity of PFC neurons at the highest dose. Pre- or posttreatment with LY354740 blocked MK801-induced changes on firing rate, burst activity, and variability of spike activity. These physiological changes coincided with a reduction in MK801-induced behavioral stereotypy by LY354740. These data indicate that activation of mGlu2/3 receptors reduces the disruptive effects of NMDA receptor hypofunction on the spontaneous spike activity and bursting of PFC neurons. This mechanism may provide a physiological basis for reversal of NMDA antagonist-induced behaviors by mGlu2/3 agonists.

[1]  J. Brotchie,et al.  Metabotropic glutamate receptor agonists inhibit endogenous glutamate release from rat striatal synaptosomes. , 1995, European journal of pharmacology.

[2]  P. Goldman-Rakic,et al.  Temporally irregular mnemonic persistent activity in prefrontal neurons of monkeys during a delayed response task. , 2003, Journal of neurophysiology.

[3]  M S Lewicki,et al.  A review of methods for spike sorting: the detection and classification of neural action potentials. , 1998, Network.

[4]  Zhen Yan,et al.  Group II metabotropic glutamate receptors enhance NMDA receptor currents via a protein kinase C‐dependent mechanism in pyramidal neurones of rat prefrontal cortex , 2004, The Journal of physiology.

[5]  G. Dawson,et al.  Interactions between LY354740, a Group II metabotropic agonist and the GABAA-benzodiazepine receptor complex in the rat elevated plus-maze , 2001, Journal of psychopharmacology.

[6]  D. Lorrain,et al.  Effects of ketamine and n-methyl-d-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268 , 2003, Neuroscience.

[7]  M. Amalric,et al.  Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders , 2003, Behavioural pharmacology.

[8]  Colin Gemmell,et al.  Deep layer prefrontal cortex unit discharge in a cue-controlled open-field environment in the freely-moving rat , 2002, Behavioural Brain Research.

[9]  E. Bézard,et al.  From single extracellular unit recording in experimental and human Parkinsonism to the development of a functional concept of the role played by the basal ganglia in motor control , 2002, Progress in Neurobiology.

[10]  G. Duncan,et al.  Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism. , 2000, The Journal of pharmacology and experimental therapeutics.

[11]  J. Coyle,et al.  Ionotropic glutamate receptors as therapeutic targets in schizophrenia. , 2002, Current drug targets. CNS and neurological disorders.

[12]  R. Nicoll,et al.  NMDA-receptor-dependent synaptic plasticity: multiple forms and mechanisms , 1993, Trends in Neurosciences.

[13]  E. Buffalo,et al.  Acute behavioral effects of MK-801 in rhesus monkeys: Assessment using an operant test battery , 1994, Pharmacology Biochemistry and Behavior.

[14]  A. Carlsson,et al.  Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease , 1990, Trends in Neurosciences.

[15]  A. Belger,et al.  NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development , 2003, Psychopharmacology.

[16]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[17]  D. Weinberger,et al.  Dopamine, the prefrontal cortex and schizophrenia , 1997, Journal of psychopharmacology.

[18]  Jing Hao.  Figure , 1972, Analysing Scientific Discourse From a Systemic Functional Linguistic Perspective.

[19]  Carol A. Tamminga,et al.  Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia , 1995, Neuropsychopharmacology.

[20]  C. Swanson,et al.  The mGlu2/3 receptor agonist, LY354740, blocks immobilization‐induced increases in noradrenaline and dopamine release in the rat medial prefrontal cortex , 2003, Journal of neurochemistry.

[21]  Bita Moghaddam,et al.  Stress activation of glutamate neurotransmission in the prefrontal cortex: implications for dopamine-associated psychiatric disorders , 2002, Biological Psychiatry.

[22]  R. Anwyl,et al.  Presynaptic inhibitory action of the group II metabotropic glutamate receptor agonists, LY354740 and DCG-IV. , 1998, European journal of pharmacology.

[23]  B. Moghaddam,et al.  Activation of Glutamate Neurotransmission in the Prefrontal Cortex Sustains the Motoric and Dopaminergic Effects of Phencyclidine , 2003, Neuropsychopharmacology.

[24]  G. Aghajanian,et al.  The electrophysiology of prefrontal serotonin systems: therapeutic implications for mood and psychosis , 1998, Biological Psychiatry.

[25]  D. Javitt,et al.  Adjunctive high-dose glycine in the treatment of schizophrenia. , 2001, The international journal of neuropsychopharmacology.

[26]  J. Krystal,et al.  Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.

[27]  Bita Moghaddam,et al.  Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex , 1997, The Journal of Neuroscience.

[28]  G. Aghajanian,et al.  Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex. , 2000, The Journal of pharmacology and experimental therapeutics.

[29]  A. Crider.  Perseveration in schizophrenia. , 1997, Schizophrenia bulletin.

[30]  C. Schroeder,et al.  Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[31]  C. Legéndy,et al.  Bursts and recurrences of bursts in the spike trains of spontaneously active striate cortex neurons. , 1985, Journal of neurophysiology.

[32]  A. Malhotra,et al.  Effects of Ketamine on Thought Disorder, Working Memory, and Semantic Memory in Healthy Volunteers , 1998, Biological Psychiatry.

[33]  G. Orban,et al.  The response variability of striate cortical neurons in the behaving monkey , 2004, Experimental Brain Research.

[34]  William R. Softky,et al.  The highly irregular firing of cortical cells is inconsistent with temporal integration of random EPSPs , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[35]  D. Schoepp,et al.  In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats , 1997, Neuroscience Letters.

[36]  A. Malhotra,et al.  Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. , 1997, The American journal of psychiatry.

[37]  D. Cooper,et al.  The significance of action potential bursting in the brain reward circuit , 2002, Neurochemistry International.

[38]  R. Roth,et al.  Prefrontal cortical involvement in phencyclidine-induced activation of the mesolimbic dopamine system: behavioral and neurochemical evidence , 1998, Psychopharmacology.

[39]  D. Schoepp,et al.  Regulation of Neurotransmitter Release by Metabotropic Glutamate Receptors , 2000, Journal of neurochemistry.

[40]  D. Schoepp,et al.  Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors. , 1998, The Journal of pharmacology and experimental therapeutics.

[41]  D. McCormick,et al.  Comparative electrophysiology of pyramidal and sparsely spiny stellate neurons of the neocortex. , 1985, Journal of neurophysiology.

[42]  R. Dingledine,et al.  Involvement of N-methyl-d-aspartate Receptors in Involvement of N-methyl-d-aspartate Receptors in Epileptiform Bursting in the Rat Hippocampal Slice , 2008 .

[43]  B. Moghaddam,et al.  Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. , 1998, Science.

[44]  B. McNaughton,et al.  Firing characteristics of deep layer neurons in prefrontal cortex in rats performing spatial working memory tasks. , 1998, Cerebral cortex.

[45]  Bita Moghaddam,et al.  Bringing Order to the Glutamate Chaos in Schizophrenia , 2003, Neuron.

[46]  W. Schmidt.  Behavioural effects of NMDA-receptor antagonists. , 1994, Journal of neural transmission. Supplementum.

[47]  William R. Softky,et al.  Comparison of discharge variability in vitro and in vivo in cat visual cortex neurons. , 1996, Journal of neurophysiology.

[48]  L. Abbott,et al.  Responses of neurons in primary and inferior temporal visual cortices to natural scenes , 1997, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[49]  Cheng-Yao Chen,et al.  Escherichia coli nucleoside diphosphate kinase does not act as a uracil-processing DNA repair nuclease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Herbert Weingartner,et al.  NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers , 1996, Neuropsychopharmacology.

[51]  F. J. White,et al.  L-type calcium channels modulate glutamate-driven bursting activity in the nucleus accumbens in vivo , 2000, Brain Research.

[52]  Bita Moghaddam,et al.  Glutamate receptors in the rat medial prefrontal cortex regulate set-shifting ability. , 2003, Behavioral neuroscience.

[53]  A. Dickinson,et al.  Neuronal coding of prediction errors. , 2000, Annual review of neuroscience.

[54]  J. Olney,et al.  Glutamate receptor dysfunction and schizophrenia. , 1995, Archives of general psychiatry.

[55]  D. Jane,et al.  Pharmacological agents acting at subtypes of metabotropic glutamate receptors , 1999, Neuropharmacology.

[56]  M. Feenstra,et al.  Behavioral arousal and increased dopamine efflux after blockade of NMDA-receptors in the prefrontal cortex are dependent on activation of glutamatergic neurotransmission , 2002, Neuropharmacology.

[57]  W. Shi,et al.  Dendritic Glutamate-Induced Bursting in the Prefrontal Cortex: Further Characterization and Effects of Phencyclidine , 2003, Journal of Pharmacology and Experimental Therapeutics.

[58]  D. Schoepp,et al.  The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats. , 1999, The Journal of pharmacology and experimental therapeutics.

[59]  J. Vitek,et al.  Burst and oscillation as disparate neuronal properties , 1996, Journal of Neuroscience Methods.

[60]  A. P. Georgopoulos,et al.  Variability and Correlated Noise in the Discharge of Neurons in Motor and Parietal Areas of the Primate Cortex , 1998, The Journal of Neuroscience.

[61]  B. Moghaddam,et al.  Corticolimbic Dopamine Neurotransmission Is Temporally Dissociated from the Cognitive and Locomotor Effects of Phencyclidine , 1998, The Journal of Neuroscience.

[62]  F. Bloom,et al.  Psychopharmacology: The Fourth Generation of Progress , 1995 .

[63]  Bita Moghaddam,et al.  NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[64]  Bruno Poucet,et al.  Searching for spatial unit firing in the prelimbic area of the rat medial prefrontal cortex , 1997, Behavioural Brain Research.

[65]  P. Conn,et al.  Direct and indirect modulation of the N-methyl D-aspartate receptor. , 2002, Current drug targets. CNS and neurological disorders.

[66]  W. Spooren,et al.  Pharmacological and endocrinological characterisation of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608). , 2002, European journal of pharmacology.

[67]  E. Miller,et al.  An integrative theory of prefrontal cortex function. , 2001, Annual review of neuroscience.

[68]  D. Cyril D’Souza,et al.  Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects , 2005, Psychopharmacology.

[69]  A. Carlsson,et al.  Glycine and D-serine decrease MK-801-induced hyperactivity in mice , 2005, Journal of Neural Transmission.

[70]  B. Moghaddam,et al.  Distinct contributions of glutamate and dopamine receptors to temporal aspects of rodent working memory using a clinically relevant task , 2001, Psychopharmacology.

[71]  W. Koek,et al.  MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. , 1988, The Journal of pharmacology and experimental therapeutics.

[72]  S. Nakanishi,et al.  Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent , 2004, Neuropharmacology.

[73]  L. Levine,et al.  LY354740, an mGlu2/3 Receptor Agonist as a Novel Approach to Treat Anxiety/Stress , 2003, Stress.

[74]  E. Pralong,et al.  Activation of Metabotropic Glutamate 5 and NMDA Receptors Underlies the Induction of Persistent Bursting and Associated Long-Lasting Changes in CA3 Recurrent Connections , 2003, The Journal of Neuroscience.

[75]  J. Tracy,et al.  Repetitive behaviors in schizophrenia: a single disturbance or discrete symptoms? , 1996, Schizophrenia Research.

[76]  Tamara Hershey,et al.  Ketamine-Induced NMDA Receptor Hypofunction as a Model of Memory Impairment and Psychosis , 1999, Neuropsychopharmacology.

[77]  B. Moghaddam,et al.  NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.